Astellas Pharma Inc. AstraZeneca plc
Bristol Myers Squibb Company (BMS)
Gilead Sciences Inc. Johnson & Johnson
Merck KGaA
Novartis International AG
Pfizer Inc. Sanofi S.A.
Published | Pages | Publisher | Report code |
---|---|---|---|
Aug 2022 | 71 | GEN Consulting | ASDR-607553 |
Astellas Pharma Inc. AstraZeneca plc
Bristol Myers Squibb Company (BMS)
Gilead Sciences Inc. Johnson & Johnson
Merck KGaA
Novartis International AG
Pfizer Inc. Sanofi S.A.